marketcaparena
Search

    NRIX

    Nurix Therapeutics, Inc.

    Company overview

    Market capitalization
    $2.46B
    Employees
    317
    Latest publication
    2026-09-29
    About Nurix Therapeutics, Inc.

    Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-05-31 · USD
    Total Revenue9,043,000USD
    Research Development87,653,000USD
    General And Administrative Expenses15,594,000USD
    Total Operating Expenses103,247,000USD
    Operating Income-94,204,000USD
    Total Other Income Expense Net4,398,000USD
    Income Before Tax-89,806,000USD
    Income Tax Expense-271,000USD
    Net Income-89,535,000USD
    SourceDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20222022-11-30 · USDFY 20212021-11-30 · USDFY 20202020-11-30 · USD
    Total Revenue38,627,000USD29,750,000USD17,820,000USD
    Cost Of Revenue10,808,000USD6,082,000USD66,494,000USD
    Gross Profit38,627,000USD29,750,000USD17,820,000USD
    Research Development184,497,000USD116,434,000USD66,494,000USD
    Selling General Administrative37,997,000USD31,202,000USD16,309,000USD
    Total Operating Expenses222,494,000USD147,636,000USD82,803,000USD
    Operating Income-183,867,000USD-117,886,000USD-64,983,000USD
    Interest Income3,507,000USD823,000USD1,206,000USD
    Interest Expense14,315,000USD6,905,000USD3,386,000USD
    Net Interest Income3,507,000USD823,000USD1,206,000USD
    Income Before Tax-180,360,000USD-117,063,000USD-63,777,000USD
    Income Tax Expense-14,315,000USD131,000USD-20,535,000USD
    Tax Provision0USD131,000USD-20,535,000USD
    Net Income-166,045,000USD-117,194,000USD-43,242,000USD
    Net Income From Continuing Ops-180,360,000USD-117,194,000USD-43,242,000USD
    Ebit-183,867,000USD-117,886,000USD-64,983,000USD
    Ebitda-173,059,000USD-111,804,000USD-62,803,000USD
    Depreciation And Amortization10,808,000USD6,082,000USD2,180,000USD
    Reconciled Depreciation10,808,000USD6,082,000USD2,180,000USD
    Total Other Income Expense Net3,507,000USD823,000USD1,206,000USD
    Non Operating Income Net Other3,507,000USD823,000USD1,206,000USD
    Net Income Applicable To Common Shares-180,360,000USD-117,194,000USD-43,242,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-05-31 · USDQ1 20262026-02-28 · USDQ4 20252025-11-30 · USDQ3 20252025-08-31 · USDQ2 20252025-05-31 · USDQ1 20252025-02-28 · USDQ4 20242024-11-30 · USDQ3 20242024-08-31 · USD
    Total Assets535,540,000USD636,130,000USD688,135,000USD522,472,000USD591,555,000USD615,043,000USD669,343,000USD513,600,000USD
    Cash And Equivalents67,685,000USD———————
    Total Current Assets456,481,000USD554,394,000USD606,819,000USD440,603,000USD515,330,000USD563,703,000USD619,387,000USD456,043,000USD
    Other Current Assets12,952,000USD11,262,000USD13,878,000USD11,774,000USD10,549,000USD14,023,000USD8,304,000USD7,191,000USD
    Other Non Current Assets7,977,000USD———————
    Total Liabilities132,913,000USD———————
    Total Current Liabilities72,020,000USD92,199,000USD86,471,000USD82,350,000USD75,614,000USD89,988,000USD95,854,000USD86,296,000USD
    Total Stockholder Equity402,627,000USD480,893,000USD538,747,000USD372,252,000USD447,603,000USD480,917,000USD526,993,000USD376,856,000USD
    Total Equity Including Noncontrolling Interest402,627,000USD———————
    Deferred Revenue13,324,000USD———————
    Deferred Revenue Non Current5,971,000USD———————
    Property Plant Equipment Net70,114,000USD73,354,000USD73,007,000USD73,526,000USD68,987,000USD44,810,000USD45,896,000USD44,152,000USD
    Accounts Payable12,208,000USD10,293,000USD11,215,000USD8,609,000USD5,954,000USD8,397,000USD11,482,000USD3,918,000USD
    Short Term Debt3,221,000USD3,202,000USD2,824,000USD3,791,000USD5,235,000USD6,639,000USD8,014,000USD6,553,000USD
    Common Stock104,000USD103,000USD102,000USD77,000USD76,000USD76,000USD76,000USD67,000USD
    Retained Earnings-1,179,935,000USD-1,090,400,000USD-1,003,226,000USD-925,005,000USD-838,584,000USD-795,120,000USD-738,769,000USD-680,220,000USD
    Accumulated Other Comprehensive Income-145,000USD56,000USD105,000USD119,000USD-20,000USD226,000USD150,000USD344,000USD
    Total Liab—155,237,000USD149,388,000USD150,220,000USD143,952,000USD134,126,000USD142,350,000USD136,744,000USD
    Other Current Liab—59,949,999USD54,852,000USD43,957,000USD36,096,000USD43,029,000USD36,757,000USD26,922,000USD
    Capital Stock—103,000USD102,000USD77,000USD76,000USD76,000USD76,000USD67,000USD
    Cash—71,195,000USD246,960,000USD78,438,000USD84,260,000USD75,916,000USD109,997,000USD99,044,000USD
    Cash And Short Term Investments—540,732,000USD592,941,000USD428,829,000USD485,781,000USD549,680,000USD609,583,000USD448,052,000USD
    Current Deferred Revenue—18,754,000USD17,580,000USD25,993,000USD27,420,000USD30,591,000USD38,364,000USD47,997,000USD
    Net Debt—-12,540,000USD-191,230,000USD-21,952,000USD-32,329,000USD-49,293,000USD-81,694,000USD-71,901,000USD
    Short Long Term Debt Total—58,655,000USD55,730,000USD56,486,000USD51,931,000USD26,623,000USD28,303,000USD27,143,000USD
    Short Term Investments—469,537,000USD345,981,000USD350,391,000USD401,521,000USD473,764,000USD499,586,000USD349,008,000USD
    Net Receivables—2,400,000USD—1,700,000USD19,000,000USD9,100,000USD1,500,000USD800,000USD
    Property Plant Equipment Gross—113,078,000USD110,789,000USD114,258,000USD107,691,000USD81,574,000USD80,398,000USD76,254,000USD
    Common Stock Shares Outstanding—110,071,668shares95,089,961shares84,159,336shares83,882,477shares83,560,795shares78,410,655shares72,779,381shares
    Non Current Assets Total—81,736,000USD81,316,000USD81,869,000USD76,225,000USD51,340,000USD49,956,000USD57,557,000USD
    Non Current Liabilities Total—63,038,000USD62,917,000USD67,870,000USD68,338,000USD44,138,000USD46,496,000USD50,448,000USD
    Non Currrent Assets Other—8,382,000USD8,309,000USD8,343,000USD7,238,000USD5,629,000USD4,060,000USD3,933,000USD
    Net Working Capital—462,195,000USD520,348,000USD358,253,000USD439,716,000USD473,715,000USD523,533,000USD369,747,000USD
    Unclassified Non Current Liabilities—63,038,000USD62,917,000USD67,870,000USD68,338,000USD44,138,000USD46,496,000USD50,448,000USD
    Unclassified Equity—1,571,031,000USD1,541,664,000USD1,296,984,000USD1,286,055,000USD1,275,659,000USD1,265,460,000USD1,056,598,000USD
    Unclassified Current Assets—————-9,100,000USD——
    Unclassified Current Liabilities—————1,332,000USD1,237,000USD—
    Long Term Investments——————0USD9,472,000USD
    Inventory———————-800,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-11-30 · USDFY 20242024-11-30 · USDFY 20232023-11-30 · USDFY 20222022-11-30 · USDFY 20212021-11-30 · USDFY 20202020-11-30 · USDFY 20192019-11-30 · USDFY 20182018-11-30 · USD
    Total Assets688,135,000USD669,343,000USD355,598,000USD416,759,000USD476,771,000USD396,343,000USD44,048,000USD45,397,000USD
    Other Current Assets13,878,000USD8,304,000USD6,795,000USD9,308,000USD9,194,000USD5,940,000USD1,634,000USD1,615,000USD
    Total Liab149,388,000USD142,350,000USD155,105,000USD113,063,000USD134,469,000USD106,074,000USD53,567,000USD34,049,000USD
    Total Stockholder Equity538,747,000USD526,993,000USD200,493,000USD303,696,000USD342,302,000USD290,269,000USD-57,714,000USD-36,847,000USD
    Other Current Liab54,852,000USD36,757,000USD24,940,000USD22,301,000USD14,520,000USD8,254,000USD4,927,000USD3,115,000USD
    Common Stock102,000USD76,000USD49,000USD47,000USD45,000USD39,000USD4,000USD3,000USD
    Capital Stock102,000USD76,000USD49,000USD47,000USD45,000USD39,000USD4,000USD3,000USD
    Retained Earnings-1,003,226,000USD-738,769,000USD-545,200,000USD-401,252,000USD-220,892,000USD-103,698,000USD-60,456,000USD-38,757,000USD
    Cash246,960,000USD109,997,000USD54,627,000USD64,474,000USD80,506,000USD119,356,000USD34,816,000USD25,591,000USD
    Cash And Short Term Investments592,941,000USD609,583,000USD287,908,000USD309,141,000USD295,720,000USD281,148,000USD37,720,000USD39,039,000USD
    Total Current Assets606,819,000USD619,387,000USD295,503,000USD318,449,000USD311,118,000USD298,434,000USD39,354,000USD40,654,000USD
    Total Current Liabilities86,471,000USD95,854,000USD86,958,000USD70,655,000USD66,258,000USD44,539,000USD16,137,000USD32,832,000USD
    Current Deferred Revenue17,580,000USD38,364,000USD48,098,000USD37,633,000USD41,212,000USD32,799,000USD9,612,000USD28,420,000USD
    Net Debt-191,230,000USD-81,694,000USD-24,013,000USD-52,510,000USD-67,470,000USD-119,356,000USD-34,816,000USD-25,591,000USD
    Short Term Debt2,824,000USD8,014,000USD7,489,000USD5,530,000USD3,847,000USD7,628,000USD4,618,000USD2,839,000USD
    Short Long Term Debt Total55,730,000USD28,303,000USD30,614,000USD11,964,000USD13,036,000USD———
    Short Term Investments345,981,000USD499,586,000USD233,281,000USD244,667,000USD215,214,000USD161,792,000USD2,904,000USD13,448,000USD
    Accounts Payable11,215,000USD11,482,000USD6,401,000USD5,064,000USD6,650,000USD3,412,000USD1,598,000USD1,297,000USD
    Property Plant Equipment Net73,007,000USD45,896,000USD47,950,000USD29,508,000USD25,345,000USD6,672,000USD3,871,000USD4,422,000USD
    Property Plant Equipment Gross110,789,000USD80,398,000USD74,199,000USD29,508,000USD25,345,000USD6,672,000USD3,871,000USD4,422,000USD
    Accumulated Other Comprehensive Income105,000USD150,000USD-655,000USD-4,319,000USD-608,000USD87,000USD-2,000USD-4,000USD
    Common Stock Shares Outstanding86,666,907shares67,120,266shares54,337,901shares48,607,990shares42,895,383shares15,673,424shares38,845,196shares16,106,403shares
    Non Current Assets Total81,316,000USD49,956,000USD60,095,000USD98,310,000USD165,653,000USD97,909,000USD4,694,000USD4,743,000USD
    Non Current Liabilities Total62,917,000USD46,496,000USD68,147,000USD42,408,000USD68,211,000USD61,535,000USD85,625,000USD49,412,000USD
    Non Currrent Assets Other8,309,000USD4,060,000USD4,724,000USD4,923,000USD3,119,000USD347,000USD317,000USD151,000USD
    Net Working Capital520,348,000USD523,533,000USD208,545,000USD247,794,000USD244,860,000USD253,895,000USD23,217,000USD7,822,000USD
    Unclassified Non Current Liabilities62,917,000USD46,496,000USD68,147,000USD-36,474,000USD-59,522,000USD—46,458,000USD46,978,000USD
    Unclassified Equity1,541,664,000USD1,265,460,000USD746,250,000USD709,173,000USD563,712,000USD393,802,000USD2,736,000USD1,908,000USD
    Long Term Investments—0USD7,421,000USD63,879,000USD137,189,000USD90,890,000USD506,000USD0USD
    Net Receivables—1,500,000USD800,000USD1,100,000USD6,204,000USD11,346,000USD——
    Unclassified Current Liabilities—1,237,000USD———-7,554,000USD-4,618,000USD-2,839,000USD
    Deferred Long Term Liab———500,000USD500,000USD———
    Other Liab———35,974,000USD59,022,000USD61,535,000USD37,430,000USD1,217,000USD
    Other Assets———4,923,000USD3,119,000USD91,237,000USD317,000USD321,000USD
    Inventory———-1,100,000USD1USD———
    Non Current Liabilities Other———42,408,000USD68,211,000USD850,000USD1,737,000USD1,217,000USD
    Net Tangible Assets———303,696,000USD342,302,000USD290,269,000USD-57,714,000USD-36,847,000USD
    Unclassified Non Current Assets———-4,923,000USD-3,119,000USD-91,237,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-05-31 · USDQ1 20262026-02-28 · USDQ4 20252025-11-30 · USDQ3 20252025-08-31 · USDQ2 20252025-05-31 · USDQ1 20252025-02-28 · USDQ4 20242024-11-30 · USDQ3 20242024-08-31 · USD
    Net Income-89,535,000USD-87,174,000USD-78,221,000USD-86,421,000USD-43,464,000USD-56,351,000USD-58,549,000USD-48,956,000USD
    Depreciation3,850,000USD3,776,000USD4,631,000USD5,000,000USD5,097,000USD4,128,000USD4,303,000USD4,146,000USD
    Stock Based Compensation11,388,000USD9,404,000USD9,086,000USD9,772,000USD10,385,000USD8,722,000USD8,508,000USD8,754,000USD
    Other Non Cash Items-18,378,000USD-1,818,000USD-1,778,000USD-2,196,999USD-2,701,000USD-3,557,000USD-3,462,000USD-3,420,000USD
    Change In Working Capital-3,898,000USD3,898,000USD-1,550,000USD16,460,999USD-32,478,000USD-14,029,000USD449,000USD-2,701,000USD
    Total Cash From Operating Activities-96,573,000USD-71,914,000USD-67,832,000USD-57,385,000USD-63,161,000USD-61,087,000USD-48,751,000USD-42,177,000USD
    Capital Expenditures-1,936,000USD-1,045,000USD-5,131,000USD-2,711,000USD-2,675,000USD-3,485,000USD-2,105,000USD-2,347,000USD
    Free Cash Flow-98,509,000USD-72,959,000USD-72,963,000USD-60,096,000USD-65,836,000USD-64,572,000USD-50,856,000USD-44,524,000USD
    Investments94,933,000USD-122,781,000USD5,477,000USD50,475,000USD71,499,000USD25,533,000USD-140,817,000USD-21,339,000USD
    Total Cashflows From Investing Activities92,997,000USD-123,826,000USD346,000USD50,475,000USD71,499,000USD25,533,000USD-140,817,000USD-21,339,000USD
    Total Cash From Financing Activities66,000USD19,975,000USD236,008,000USD1,155,000USD6,000USD1,473,000USD200,521,000USD45,770,000USD
    Issuance Of Capital Stock0USD18,004,000USD234,762,000USD0USD0USD0USD199,072,000USD41,872,000USD
    Change In Cash-3,510,000USD-175,765,000USD168,522,000USD-5,755,000USD8,344,000USD-34,081,000USD10,953,000USD-17,746,000USD
    Begin Period Cash Flow72,163,000USD247,928,000USD79,406,000USD85,161,000USD76,817,000USD110,898,000USD99,945,000USD117,691,000USD
    End Period Cash Flow68,653,000USD72,163,000USD246,960,000USD79,406,000USD85,161,000USD76,817,000USD110,898,000USD99,945,000USD
    Sale Purchase Of Stock—1,596,000USD—2,229,000USD1,252,000USD——15,000USD
    Other Cashflows From Financing Activities—19,975,000USD——6,000USD1,473,000USD1,449,000USD3,898,000USD
    Unclassified Financing Cash Flow—-1,596,000USD—-1,074,000USD-1,252,000USD——41,857,000USD
    Unclassified Investing Cash Flow———2,711,000USD2,675,000USD3,485,000USD2,105,000USD40,744,000USD
    Change To Account Receivables————-19,000,000USD—0USD0USD
    Other Cashflows From Investing Activities———————-38,397,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-11-30 · USDFY 20242024-11-30 · USDFY 20232023-11-30 · USDFY 20212021-11-30 · USDFY 20202020-11-30 · USDFY 20192019-11-30 · USDFY 20182018-11-30 · USD
    Net Income-264,457,000USD-193,569,000USD-143,948,000USD-117,194,000USD-43,242,000USD-21,699,000USD-9,428,000USD
    Depreciation18,856,000USD16,428,000USD13,654,000USD6,082,000USD2,180,000USD2,354,000USD2,988,000USD
    Stock Based Compensation37,965,000USD33,929,000USD33,673,000USD15,800,000USD4,301,000USD510,000USD431,000USD
    Other Non Cash Items-10,233,000USD-10,971,000USD-4,865,000USD1,834,000USD273,000USD-109,000USD-6,000USD
    Change In Working Capital-31,596,000USD-18,401,000USD20,121,000USD9,113,000USD36,408,000USD19,545,000USD-25,306,000USD
    Total Cash From Operating Activities-249,465,000USD-172,584,000USD-81,365,000USD-84,365,000USD-80,000USD601,000USD-31,675,000USD
    Capital Expenditures-14,002,000USD-9,273,000USD-8,401,000USD-5,661,000USD-4,553,000USD-1,651,000USD-1,595,000USD
    Free Cash Flow-263,467,000USD-181,857,000USD-89,766,000USD-90,026,000USD-4,633,000USD-1,050,000USD-33,270,000USD
    Investments161,855,000USD-257,713,000USD68,301,000USD-102,590,000USD-254,404,000USD8,498,000USD39,994,000USD
    Total Cashflows From Investing Activities147,853,000USD-257,713,000USD68,301,000USD-108,251,000USD-254,404,000USD8,498,000USD39,994,000USD
    Total Cash From Financing Activities238,642,000USD485,667,000USD3,217,000USD153,882,000USD339,024,000USD126,000USD529,000USD
    Issuance Of Capital Stock234,762,000USD478,495,000USD0USD150,157,000USD338,061,000USD——
    Change In Cash137,030,000USD55,370,000USD-9,847,000USD-38,734,000USD84,540,000USD9,225,000USD8,848,000USD
    Begin Period Cash Flow109,997,000USD55,528,000USD65,375,000USD119,526,000USD34,986,000USD25,761,000USD16,913,000USD
    End Period Cash Flow247,928,000USD110,898,000USD55,528,000USD80,792,000USD119,526,000USD34,986,000USD25,761,000USD
    Unclassified Financing Cash Flow3,880,000USD——150,158,000USD218,154,000USD——
    Change To Account Receivables—0USD0USD-6,000,000USD-11,346,000USD-7,500,000USD12,374,000USD
    Other Cashflows From Financing Activities—7,172,000USD3,217,000USD3,725,000USD120,877,000USD126,000USD529,000USD
    Unclassified Investing Cash Flow—9,273,000USD8,401,000USD102,590,000USD254,404,000USD-8,498,000USD1,589,000USD
    Change To Inventory———6,774,000USD11,346,000USD——
    Change To Liabilities———8,339,000USD49,413,000USD17,187,000USD-37,968,000USD
    Sale Purchase Of Stock———-1,000USD-7,000USD-16,000USD-2,000USD
    Cash And Cash Equivalents Changes———-38,734,000USD84,540,000USD——
    Other Cashflows From Investing Activities———-102,590,000USD-249,851,000USD10,149,000USD6,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-05-31ProductCollaboration Revenue9,043,000USDDisclosure
    Q2 2026Quarterly · 2026-05-31ProductLicense Revenue0USDDisclosure
    FY 2025Yearly · 2025-11-30ProductCollaboration Revenue53,980,000USD0001549595-26-000016
    FY 2025Yearly · 2025-11-30ProductLicense Revenue30,000,000USD0001549595-26-000016
    Q3 2025Quarterly · 2025-08-31ProductCollaboration Revenue7,894,000USD0001549595-25-000113
    Q3 2025Quarterly · 2025-08-31ProductLicense Revenue0USD0001549595-25-000113
    Q2 2025Quarterly · 2025-05-31ProductCollaboration Revenue14,056,000USD0001549595-25-000095
    Q2 2025Quarterly · 2025-05-31ProductLicense Revenue30,000,000USD0001549595-25-000095
    FY 2024Yearly · 2024-11-30ProductCollaboration Revenue54,549,000USD0001549595-26-000016
    FY 2024Yearly · 2024-11-30ProductLicense Revenue0USD0001549595-26-000016
    Q3 2024Quarterly · 2024-08-31ProductCollaboration Revenue12,588,000USD0001549595-25-000113
    Q3 2024Quarterly · 2024-08-31ProductLicense Revenue0USD0001549595-25-000113
    Q2 2024Quarterly · 2024-05-31ProductCollaboration Revenue12,092,000USD0001549595-25-000095
    Q2 2024Quarterly · 2024-05-31ProductLicense Revenue0USD0001549595-25-000095
    FY 2023Yearly · 2023-11-30ProductCollaboration Revenue56,987,000USD0001549595-26-000016
    FY 2023Yearly · 2023-11-30ProductLicense Revenue20,000,000USD0001549595-26-000016
    Q3 2023Quarterly · 2023-08-31ProductCollaboration Revenue18,467,000USD0001549595-24-000131
    Q3 2023Quarterly · 2023-08-31ProductLicense Revenue0USD0001549595-24-000131
    Q2 2023Quarterly · 2023-05-31ProductCollaboration Revenue10,676,000USD0001549595-24-000098
    Q2 2023Quarterly · 2023-05-31ProductLicense Revenue20,000,000USD0001549595-24-000098
    FY 2022Yearly · 2022-11-30ProductCollaboration Revenue38,627,000USD0001549595-25-000016
    FY 2022Yearly · 2022-11-30ProductLicense Revenue0USD0001549595-25-000016
    Q3 2022Quarterly · 2022-08-31ProductCollaboration Revenue10,791,000USD0001549595-23-000048
    Q3 2022Quarterly · 2022-08-31ProductLicense Revenue0USD0001549595-23-000048

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.